{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:17:42Z","timestamp":1780406262559,"version":"3.54.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRP"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In this study, [64Cu]Cu-NODAGA-RGD-BBN was prepared and its\npreclinical assessments were evaluated for PET imaging of GRPR overexpressing tumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>NODAGA-RGD-BBN heterodimer peptide was successfully labeled with cyclotronproduced\ncopper-64 at optimized conditions. The radiochemical purity of the radiotracer was\nchecked by HPLC and RTLC methods. The stability of the radiolabeled compound was assessed\nin PBS (4\u00b0C) and in human blood serum (37\u00b0C). Binding affinity and internalization of\n[64Cu]Cu-NODAGA-RGD-BBN were studied on PC3, LNCaP, and CHO cell lines. The biodistribution\nof the radiotracer was evaluated in normal and tumor-bearing mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>[64Cu]Cu-NODAGA-RGD-BBN was prepared with radiochemical purity &gt;99 \u00b1 0.7%\n(HPLC\/ITLC) and specific activity of 18.5 \u00b1 2.2 TBq\/mmol. The radiotracer showed high stability\nin PBS (95 \u00b1 1.05%) and in human blood serum (96 \u00b1 1.24%) and, high affinity to the\nGRP expressing tumor cells. [64Cu]Cu-NODAGA-RGD-BBN showed hydrophilic (log p =\n-1.14) and agonistic nature. The biodistribution and imaging studies demonstrated high uptake\nat the tumor site at all intervals post-injection and 3-4 h post-injection can be considered an appropriate\ntime of imaging.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results indicated that [64Cu]Cu-NODAGA-RGD-BBN radiolabeled heterodimer\npeptide can be considered as a high-potential agent for PET imaging of GRPRoverexpressing\ntumors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118744710246897240209070005","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T04:55:49Z","timestamp":1709009749000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of [<sup>64<\/sup>Cu]Cu-NODAGA-RGD-BBN as a Novel Radiotracer for Dual Integrin and GRPR-targeted Tumor PET Imaging"],"prefix":"10.2174","volume":"18","author":[{"given":"Naeimeh","family":"Amraee","sequence":"first","affiliation":[{"name":"Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Alirezapour","sequence":"additional","affiliation":[{"name":"Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hosntalab","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Hadadi","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Yousefnia","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118744710246897240209070005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227335\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118744710246897240209070005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:49:53Z","timestamp":1735069793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227335\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118744710246897240209070005","relation":{},"ISSN":["1874-4710"],"issn-type":[{"value":"1874-4710","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}